SPECS v2.0

  • Research type

    Research Study

  • Full title

    A mechanistic trial comparing Standard care versus Prehabilitation in patients undergoing Elective hepatopancreatobiliary (HPB) and colorectal Cancer Surgery: A feasibility study

  • IRAS ID

    290723

  • Contact name

    Joel Lambert

  • Contact email

    joel.lambert@elht.nhs.uk

  • Sponsor organisation

    East Lancashire Hospitals NHS Trust

  • Clinicaltrials.gov Identifier

    NCT04880772

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    Preliminary qualitative and quantitative studies suggest that there are benefits (reduced length of stay, improved cardiorespiratory function, reduced postoperative complications and improved quality of life) when prehabilitation is used with the context of cancer care. In 2017 Macmillian Cancer Support developed a strategic 'Evidence and Insight' review on prehabilitation. The outcome of this was to incorporate prehabilitation into routine cancer care and to develop principles and guidance for prehabilitation. This study aims to support this vision and answer some of the questions on the patients who are most likely to benefit from prehabilitation and to quantify some of these benefits by investigating the molecular processes that influence clinical changes.

    This study has 2 main objectives:

    • To investigate the cardiovascular responses to prehabilitation. This will be determined by measuring improvements in anaerobic threshold and peak oxygen consumption.

    • To investigate the biological responses to prehabilitation. This will be determined by analysing the types and amounts of circulatory inflammatory cytokines in skeletal muscle and blood.

    All patients undergoing colorectal and hepato-pancreatobiliary cancer surgery would be eligible. The aim is to recruit patients from multi-disciplinary team meetings with the support of local cancer care specialist teams. We intend to recruit from a cohort at East Lancashire Hospital Trust(ELHT). The study will be undertaken on different sites Clinical/Academic/Laboratory. Lancaster University will provide technical and academic support. The laboratory analyses will be performed at the biosciences laboratory at Lancaster University. Some of the exercise- related analyses will take place at the human performance lab at Lancaster University.

  • REC name

    Yorkshire & The Humber - Leeds East Research Ethics Committee

  • REC reference

    21/YH/0069

  • Date of REC Opinion

    26 Apr 2021

  • REC opinion

    Further Information Favourable Opinion